-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
【Hot attention from Chemical Machinery Equipment Network ] Traditional Chinese medicine industry is an important part of China's pharmaceutical industry, and the country attaches great importance to the development of Chinese medicine.
Affected by the special period this year, more and more local laws and regulations have been continuously promulgated and implemented relevant supporting policies.
The industrialization of Chinese medicine has ushered in a good opportunity.
It is estimated that the market size is expected to reach 580.
6 billion yuan by 2020.
The growth rate is 8.
2%.
While the scale of the traditional Chinese medicine market continues to expand, the inheritance and innovation of traditional Chinese medicine has also "entered the fast lane".
It is necessary for the industry to strengthen the confidence in the development of traditional Chinese medicine, follow the law of traditional Chinese medicine development, inherit the essence, maintain integrity, and promote the modernization of traditional Chinese medicine.
Industrialization, to achieve high-quality development of the Chinese medicine business and industry.
Hot attention of Chemical Machinery Equipment NetworkChemical machinery and equipmentAffected by the special period this year, more and more local laws and regulations have been continuously promulgated and implemented relevant supporting policies.
The industrialization of Chinese medicine has ushered in a good opportunity.
It is estimated that the market size is expected to reach 580.
6 billion yuan by 2020.
The growth rate is 8.
2%.
While the scale of the traditional Chinese medicine market continues to expand, the inheritance and innovation of traditional Chinese medicine has also "entered the fast lane".
It is necessary for the industry to strengthen the confidence in the development of traditional Chinese medicine, follow the law of traditional Chinese medicine development, inherit the essence, maintain integrity, and promote the modernization of traditional Chinese medicine.
Industrialization, to achieve high-quality development of the Chinese medicine business and industry.
In recent news, my country’s first intelligent Chinese medicine manufacturing plant has been officially opened.
This plant has achieved a key breakthrough in the development of intelligent Chinese medicine manufacturing technology from "perceived intelligence" to "cognitive intelligence", which means that the era of Chinese medicine smart pharmaceuticals has arrived.
This plant has achieved a key breakthrough in the development of intelligent Chinese medicine manufacturing technology from "perceived intelligence" to "cognitive intelligence", which means that the era of Chinese medicine smart pharmaceuticals has arrived.
It is understood that, due to the uneven quality of Chinese medicinal materials, traditional Chinese medicinal materials have become a "blocker" on the road to high-quality development of the Chinese medicine industry.
In recent years, with the continuous development of traditional Chinese medicine pharmaceutical technology, the production mode of traditional Chinese medicine has undergone a huge transformation, gradually changing from manual to mechanization and automation, meeting the needs of large-scale production and improving the quality of medicines.
In recent years, with the continuous development of traditional Chinese medicine pharmaceutical technology, the production mode of traditional Chinese medicine has undergone a huge transformation, gradually changing from manual to mechanization and automation, meeting the needs of large-scale production and improving the quality of medicines.
At present, the manufacturing industry is moving from the information and digital age to the intelligent age.
Traditional pharmaceutical companies in the context of the "Healthy China" strategy and "China Smart Pharmaceutical 2025" also need to actively embrace innovation and start from the quality control of traditional Chinese medicine.
Gradually move towards intelligent manufacturing to help realize the upgrading of the traditional Chinese medicine industry.
Traditional pharmaceutical companies in the context of the "Healthy China" strategy and "China Smart Pharmaceutical 2025" also need to actively embrace innovation and start from the quality control of traditional Chinese medicine.
Gradually move towards intelligent manufacturing to help realize the upgrading of the traditional Chinese medicine industry.
According to the industry, through the implementation of plant-wide informatization, networking, and intelligent engineering, smart pharmaceutical factories have achieved a key breakthrough in the development of intelligent manufacturing technology of traditional Chinese medicine from "perceived intelligence" to "cognitive intelligence", which will solve the problems that have plagued pharmaceutical companies in the past.
Many technical problems, including the quality traceability of the entire chain from the planting source to the end user, and the “digital and transparent” intelligent management and control of Chinese medicine and pharmaceuticals, are conducive to improving quality and efficiency, reducing costs and controlling risks, and energy saving and emission reduction.
Many technical problems, including the quality traceability of the entire chain from the planting source to the end user, and the “digital and transparent” intelligent management and control of Chinese medicine and pharmaceuticals, are conducive to improving quality and efficiency, reducing costs and controlling risks, and energy saving and emission reduction.
It is worth noting that the manufacturing of traditional Chinese medicine involves a series of key pharmaceutical processes and production links.
No problem should occur in any one link, otherwise it will affect the quality of the medicine.
This requires a "Chinese medicine pharmaceutical brain" that can coordinate and direct the whole process of pharmaceuticals.
It is reported that the first Chinese medicine industry brain has been applied in the intelligent production line of Chinese medicine.
This is based on the perception of the pharmaceutical process and the big data of the Chinese medicine industry, using artificial intelligence methods to mine the useful information contained in the big data, and discover the knowledge of pharmaceuticals and their interactions.
Relevance, learning and understanding the laws of traditional Chinese medicine pharmacy and optimizing pharmaceutical process parameters, playing an auxiliary decision-making role in improving the quality of medicines and increasing production efficiency.
No problem should occur in any one link, otherwise it will affect the quality of the medicine.
This requires a "Chinese medicine pharmaceutical brain" that can coordinate and direct the whole process of pharmaceuticals.
It is reported that the first Chinese medicine industry brain has been applied in the intelligent production line of Chinese medicine.
This is based on the perception of the pharmaceutical process and the big data of the Chinese medicine industry, using artificial intelligence methods to mine the useful information contained in the big data, and discover the knowledge of pharmaceuticals and their interactions.
Relevance, learning and understanding the laws of traditional Chinese medicine pharmacy and optimizing pharmaceutical process parameters, playing an auxiliary decision-making role in improving the quality of medicines and increasing production efficiency.
The total land area of Zhengda Qingchunbao Smart Pharmaceutical Factory is about 172 acres.
The first phase of the project is: the intelligent chemical plant for Chinese medicine solid preparations covers an area of about 104 acres, which can produce 500 million bags of granules, 500 million tablets, and 500 million tablets per year.
Capsules, the main products include more than 30 varieties such as Guanxinning tablets, anti-aging tablets, and stomach-nourishing granules.
The first phase of the project is: the intelligent chemical plant for Chinese medicine solid preparations covers an area of about 104 acres, which can produce 500 million bags of granules, 500 million tablets, and 500 million tablets per year.
Capsules, the main products include more than 30 varieties such as Guanxinning tablets, anti-aging tablets, and stomach-nourishing granules.
Judging from the trial operation of the smart pharmaceutical factory, the quality index CPK of some key products currently reaches 1.
3-1.
6.
With continuous optimization and improvement, product operating costs have been reduced by 64% year-on-year, and production efficiency has increased by 148%.
It can be said that The goals of improving quality and efficiency, energy saving and emission reduction have been well achieved.
In this regard, the industry believes that the prospect of smart Chinese medicine is broad.
3-1.
6.
With continuous optimization and improvement, product operating costs have been reduced by 64% year-on-year, and production efficiency has increased by 148%.
It can be said that The goals of improving quality and efficiency, energy saving and emission reduction have been well achieved.
In this regard, the industry believes that the prospect of smart Chinese medicine is broad.
Original title: The era of smart Chinese medicine has arrived, and production capacity and production efficiency will be greatly improved
